Page last updated: 2024-10-26

valproic acid and Conduct Disorder

valproic acid has been researched along with Conduct Disorder in 12 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Conduct Disorder: A repetitive and persistent pattern of behavior in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviors include aggressive conduct that causes or threatens physical harm to other people or animals, nonaggressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18. (From DSM-IV, 1994)

Research Excerpts

ExcerptRelevanceReference
" Children whose aggressive behavior persisted at the conclusion of the lead-in phase were randomly assigned to receive double-blind, flexibly dosed divalproex or a placebo adjunctive to stimulant for 8 weeks."2.74Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy. ( Blader, JC; Jensen, PS; Kafantaris, V; Pliszka, SR; Schooler, NR, 2009)
"Twelve had PTSD."2.73Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial. ( Carrion, V; Chang, K; Khanzode, LA; Saxena, KS; Silverman, M; Steiner, H, 2007)
"New treatments for conduct disorder are sorely needed."2.71Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial. ( Ford, S; Matthews, Z; Petersen, ML; Saxena, K; Steiner, H, 2003)
"Successful treatment of conduct disorder remains difficult."2.71Baseline predictors of response to divalproex in conduct disorder. ( Chang, K; Khanzode, L; Saxena, K; Silverman, MA; Steiner, H, 2005)
"All patients met DSM-IV criteria for a disruptive behavior disorder (oppositional defiant disorder of conduct disorder) in addition to research criteria."1.32"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder? ( Donovan, SJ; Jensen, PS; Klein, DF; Nunes, EV; Quitkin, FM; Ross, D; Stewart, JW, 2003)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's9 (75.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blader, JC1
Schooler, NR1
Jensen, PS2
Pliszka, SR1
Kafantaris, V1
Steiner, H6
Karnik, NS1
Padhy, R1
Saxena, K4
Remsing, L1
Huemer, J1
Plattner, B1
Levy, T1
Bloch, Y1
GĂ©rardin, P1
Cohen, D1
Mazet, P1
Flament, MF1
Donovan, SJ1
Nunes, EV1
Stewart, JW1
Ross, D1
Quitkin, FM1
Klein, DF1
Petersen, ML1
Ford, S1
Matthews, Z1
Silverman, MA1
Chang, K3
Khanzode, L1
Sugden, SG1
Kile, SJ1
Farrimond, DD1
Hilty, DM1
Bourgeois, JA1
Khanzode, LA2
Kraemer, H1
Saxena, KS1
Carrion, V1
Silverman, M1
Barinaga, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Double-Blind, Placebo-Controlled Trial of Flexible Dose Divalproex Sodium Adjunctive to Stimulant Treatment for Aggressive Children With Attention-Deficit Hyperactivity Disorder[NCT00228046]Phase 440 participants (Anticipated)Interventional2004-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for valproic acid and Conduct Disorder

ArticleYear
[Pharmacotherapy for conduct disorder in children and adolescents].
    Harefuah, 2012, Volume: 151, Issue:7

    Topics: Adolescent; Aggression; Anticoagulants; Antimanic Agents; Antipsychotic Agents; Attention Deficit Di

2012

Trials

6 trials available for valproic acid and Conduct Disorder

ArticleYear
Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.
    The American journal of psychiatry, 2009, Volume: 166, Issue:12

    Topics: Adolescent; Aggression; Antimanic Agents; Attention Deficit and Disruptive Behavior Disorders; Atten

2009
Symptomatic response to divalproex in subtypes of conduct disorder.
    Child psychiatry and human development, 2011, Volume: 42, Issue:5

    Topics: Adolescent; Aggression; Antimanic Agents; Conduct Disorder; Double-Blind Method; Humans; Male; Self

2011
Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:10

    Topics: Adolescent; Aggression; Anger; Anticonvulsants; Arousal; Conduct Disorder; Crime; Dose-Response Rela

2003
Baseline predictors of response to divalproex in conduct disorder.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:12

    Topics: Adaptation, Psychological; Adolescent; Anticonvulsants; Comorbidity; Conduct Disorder; Defense Mecha

2005
Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder.
    Child psychiatry and human development, 2006,Fall, Volume: 37, Issue:1

    Topics: Adolescent; Antidepressive Agents; Conduct Disorder; Double-Blind Method; Female; Humans; Male; Soci

2006
Divalproex sodium for the treatment of PTSD and conduct disordered youth: a pilot randomized controlled clinical trial.
    Child psychiatry and human development, 2007, Volume: 38, Issue:3

    Topics: Adolescent; Anticonvulsants; Comorbidity; Conduct Disorder; Dose-Response Relationship, Drug; Double

2007

Other Studies

5 other studies available for valproic acid and Conduct Disorder

ArticleYear
Integrated treatment of aggression in the context of ADHD in children refractory to stimulant monotherapy: a window into the future of child psychopharmacology.
    The American journal of psychiatry, 2009, Volume: 166, Issue:12

    Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimul

2009
Drug treatment of conduct disorder in young people.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:5

    Topics: Adolescent; Adrenergic alpha-Agonists; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Central

2002
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aggression; Anticonvulsants; Attention Deficit and Disruptive Behavi

2003
Pharmacological intervention for cognitive deficits and aggression in frontal lobe injury.
    NeuroRehabilitation, 2006, Volume: 21, Issue:1

    Topics: Adult; Aggression; Amantadine; Cognition Disorders; Conduct Disorder; Donepezil; Frontal Lobe; Human

2006
Research risks. California probes prison teens study.
    Science (New York, N.Y.), 1999, Aug-27, Volume: 285, Issue:5432

    Topics: Adolescent; California; Clinical Trials as Topic; Conduct Disorder; Ethics Committees, Research; Gov

1999